Brief: Yakira Capital Management Calls On Atrium Therapeutics To Launch Strategic Review
20/10/2026 13:33
BRIEF-Yakira Capital Management Calls On Atrium Therapeutics To Launch Strategic Review Oct 20 (Reuters) -
YAKIRA CAPITAL MANAGEMENT CALLS ON ATRIUM THERAPEUTICS TO LAUNCH STRATEGIC REVIEW, CURB CASH SPENDING AND EXPLAIN DILUTIVE FINANCING
Source text: ID:nPn4nGkD4a
Further company coverage: RNA.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Atrium Therapeutics
See all newsBrief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Yakira Capital Management Calls On Atrium Therapeutics To Launch Strategic Review
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Atrium Therapeutics rallies after $50 mln equity raise